(±)-tert-butyl (R)-4-(4-chlorophenyl)-2-oxopyrrolidine-1-carboxylate | 192514-97-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (±)-tert-butyl (R)-4-(4-chlorophenyl)-2-oxopyrrolidine-1-carboxylate
• 英文别名: tert-butyl 4-(4-chlorophenyl)-2-oxopyrrolidine-1-carboxylate
• CAS: 192514-97-9
• 化学式: C₁₅H₁₈ClNO₃
• 分子量: 295.766
• InChiKey: OIIQWVMLKLFYIA-UHFFFAOYSA-N

物化性质

• 沸点：
  437.5±45.0 °C(Predicted)
• 密度：
  1.234±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (±)-tert-butyl (R)-4-(4-chlorophenyl)-2-oxopyrrolidine-1-carboxylate 在 三乙基硼氢化锂 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 (±)-tert-butyl (4R)-4-(4-chlorophenyl)-2-hydroxypyrrolidine-1-carboxylate
  参考文献：
  名称：

  Cu(OTf)2 催化 N,O-缩醛与异氰化物的 Ugi 型反应合成吡咯烷基和哌啶基 2-甲酰胺

  摘要：

  已经描述了用于合成吡咯烷基和哌啶基 2-甲酰胺的 Cu(OTf) 2催化的N，O-缩醛与异氰化物的Ugi 型反应。4-羟基-5-取代的脯氨酰胺可以以高非对映选择性（2,4-顺式/反式> 19:1）获得，并且提出了2,4-顺式选择性的立体选择性模型。此外，4-F-VH 032，一种新型的 VHL 配体类似物，可以通过使用本方法方便地获得。

  DOI：

  10.1039/d1cc03113a
• 作为产物：
  描述：

  3-(4-Chloro-phenyl)-3-formyloxy-pyrrolidine-1-carboxylic acid benzyl ester 在 palladium on activated charcoal ruthenium trichloride 、 sodium periodate 、 三氟化硼乙醚 、 氢气 作用下， 以 甲醇 、 四氯化碳 、 二氯甲烷 、 乙腈 为溶剂， 反应 16.25h， 生成 (±)-tert-butyl (R)-4-(4-chlorophenyl)-2-oxopyrrolidine-1-carboxylate
  参考文献：
  名称：

  New synthesis of 3-arylpyrrolines

  摘要：

  We present an easy and straightforward synthesis of 3-arylpyrrolines 4a-g by repeated treatment of 4-aryl-1,2,5,6-tetrahydropyridines 2a-g with in-chloroperoxybenzoic acid (MCPBA) and boron trifluoride etherate (BF3-OEt2). The transformation proceeds via epoxidation, ring contraction, Baeyer-Villiger oxidation and elimination reaction and affords 3-arylpyrrolines 4a-g with 61-70% yield. This facile strategy was also used to synthesize racemic baclofen (6). (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2005.12.008

文献信息

• A Versatile Route to Unstable Diazo Compounds via Oxadiazolines and their Use in Aryl-Alkyl Cross-Coupling Reactions
  作者：Andreas Greb、Jian-Siang Poh、Stephanie Greed、Claudio Battilocchio、Patrick Pasau、David C. Blakemore、Steven V. Ley

  DOI：10.1002/anie.201710445

  日期：2017.12.22

  Coupling of readily available boronic acids and diazo compounds has emerged recently as a powerful metal-free carbon-carbon bond forming method. However, the difficulty in forming the unstable diazo compound partner in a mild fashion has hitherto limited their general use and the scope of the transformation. Here, we report the application of oxadiazolines as precursors for the generation of an unstable

  作为一种有效的无金属碳-碳键形成方法，最近出现了易于获得的硼酸和重氮化合物的偶联。然而，迄今为止，以温和的方式形成不稳定的重氮化合物伴侣的困难限制了它们的一般用途和转化范围。在这里，我们报道了恶二唑啉作为前体的应用，它使用流式紫外光解法生成不稳定的重氮化合物家族，并首次用于不同的原去硼和氧化C（sp2）-C（sp3）交叉偶联过程中，具有出色的功能组容忍度。
• Microwave-Assisted Heck Arylations of Non-Activated<i>N</i>-Acyl-3-pyrrolines with Arenediazonium Tetrafluoroborates
  作者：Fernanda G. Finelli、Marla N. Godoi、Carlos R. D. Correia

  DOI：10.5935/0103-5053.20150051

  日期：——

  Successful Heck-Matsuda arylations of non-activated olefins applying microwave irradiation as an alternative heating mode are presented. Cleaner reactions were performed with arenediazonium tetrafluoroborates bearing electron-donating and electron-withdrawing groups in good to excellent yields with reaction times reduced from 3.5-18 h to 12-30 min.
• Heck arylations of N -acyl-3-pyrroline and N -acyl-1,2,5,6-tetrahydropyridine with aryldiazonium salts. Short syntheses of aryl γ- and δ-lactams, baclofen, homobaclofen and analogues
  作者：Marcos José S. Carpes、Carlos Roque D. Correia

  DOI：10.1016/s0040-4039(01)02267-5

  日期：2002.1

  Heck arylation of N-acyl-3-pyrrolines and an N-acyl-tetrahydropyridine with aryldiazonium tetrafluoroborates under phosphine-free conditions proceeded smoothly to give alpha-hydroxycarbamates (hemiaminals) or alpha-alkoxycarbamates which were oxidized to the desired gamma- and delta-lactams. Acidic hydrolysis of the gamma-lactams produced a series of arylated GABA derivatives, including baclofen, a useful therapeutic drug. in only three steps with ail overall yield of 63 76%, Starting from N-acyl-tetrahydropyridine, aryl-delta-lactams and higher homologues of baclofen can be obtained. (C) 2002 Elsevier Science Ltd. All rights reserved.